Endoscopic sleeve gastroplasty more cost-effective than with semaglutideAn economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is...
Medicare coverage for weight loss therapies could generate significant cost-offsetsA new USC Schaeffer Center white paper finds the value to society of Medicare coverage for new classes of weight loss drugs would equal...
Insurance providers in Michigan saved more than $76.5 million on diabetes drugs in the first yearA study that compared expenditures for diabetes medications before and after metabolic surgery among patients with diabetes in Michigan...
ICER finds semaglutide more effective, but more expensiveThe Institute for Clinical and Economic Review (ICER) in the US has published its revised Evidence Report assessing the comparative...
Gastric bypass better for type 2 diabeticsRoux-en-Y gastric bypass (RYGB) leads to greater weight loss and a greater rate of remission of diabetes than sleeve gastrectomy or...
Bariatric surgery cost-effective in reducing COVID-19 related morbidity and mortalityIncreasing the number of bariatric and metabolic surgeries (BMS) would be expected to reduce COVID-19-related morbidity and mortality, as...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure2 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity2 days ago